marketcaparena
Search

    JNJ

    JOHNSON & JOHNSON

    Company overview

    Market capitalization
    $655.37B
    Employees
    138,200
    Latest publication
    2026-09-29
    About JOHNSON & JOHNSON

    Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as oncology, immunology, neuroscience, pulmonary hypertension, infectious diseases, and cardiovascular and metabolism distributed through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. The MedTech segment provides a portfolio of products used in the surgery, orthopedic, cardiovascular, and vision fields distributed through wholesalers, hospitals and retailers, and used in the professional fields by physicians, nurses, hospitals, eye care professionals and clinics. This segment also offers products and enabling technologies that support joint reconstruction, trauma, spine, sports related injuries, and others, as well as open, laparoscopic, and robotic surgical procedures; instrumentation, energy devices, stapling systems, wound closure, biosurgery products, and digital and robotic technologies; breast aesthetics and reconstruction; contact lenses under the ACUVUE brand; intraocular lenses for cataract surgery, and other products used in cataract and refractive procedures under the TECNIS brand. The company was founded in 1886 and is based in New Brunswick, New Jersey.

    Company website

    Financial statements

    Income Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-28 · USDQ1 20262026-03-31 · USDQ1 20272026-03-29 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USD
    Total Revenue25,310,000,000USD24,062,000,000USD24,062,000,000USD24,564,000,000USD23,993,000,000USD23,743,000,000USD21,893,000,000USD22,520,000,000USD
    Cost Of Revenue8,051,000,000USD6,859,000,000USD8,106,000,000USD7,968,000,000USD7,303,000,000USD7,628,000,000USD7,357,000,000USD7,128,000,000USD
    Gross Profit17,259,000,000USD17,203,000,000USD15,956,000,000USD16,596,000,000USD16,690,000,000USD16,115,000,000USD14,536,000,000USD15,392,000,000USD
    Research Development3,653,000,000USD3,527,000,000USD3,527,000,000USD4,252,000,000USD3,672,000,000USD3,516,000,000USD3,225,000,000USD5,298,000,000USD
    Selling General Administrative6,432,000,000USD6,034,000,000USD6,034,000,000USD6,953,000,000USD5,922,000,000USD5,789,000,000USD5,012,000,000USD6,253,000,000USD
    Other Operating Expenses34,000,000USD———————
    Total Operating Expenses10,119,000,000USD10,808,000,000USD9,561,000,000USD11,005,000,000USD9,594,000,000USD9,305,000,000USD8,237,000,000USD11,551,000,000USD
    Operating Income7,140,000,000USD6,395,000,000USD6,395,000,000USD5,591,000,000USD7,096,000,000USD6,810,000,000USD6,299,000,000USD3,841,000,000USD
    Total Other Income Expense Net-393,000,000USD-405,000,000USD-405,000,000USD-625,000,000USD397,000,000USD-319,000,000USD7,332,000,000USD46,000,000USD
    Interest Income219,000,000USD229,000,000USD229,000,000USD237,000,000USD227,000,000USD260,000,000USD332,000,000USD281,000,000USD
    Interest Expense281,000,000USD272,000,000USD272,000,000USD214,000,000USD245,000,000USD308,000,000USD204,000,000USD137,000,000USD
    Income Before Tax6,747,000,000USD5,990,000,000USD5,990,000,000USD4,966,000,000USD7,493,000,000USD6,491,000,000USD13,631,000,000USD3,887,000,000USD
    Income Tax Expense1,213,000,000USD755,000,000USD755,000,000USD-150,000,000USD2,341,000,000USD954,000,000USD2,632,000,000USD456,000,000USD
    Net Income5,534,000,000USD5,235,000,000USD5,235,000,000USD5,116,000,000USD5,152,000,000USD5,537,000,000USD10,999,000,000USD3,431,000,000USD
    Unclassified Operating Expenses—1,247,000,000USD—-200,000,000USD————
    Net Interest Income—-43,000,000USD—23,000,000USD-18,000,000USD-48,000,000USD128,000,000USD144,000,000USD
    Tax Provision—755,000,000USD—-150,000,000USD2,341,000,000USD954,000,000USD2,632,000,000USD456,000,000USD
    Net Income From Continuing Ops—5,235,000,000USD—5,116,000,000USD5,152,000,000USD5,537,000,000USD10,999,000,000USD3,431,000,000USD
    Ebit—6,262,000,000USD—5,180,000,000USD7,511,000,000USD6,799,000,000USD13,835,000,000USD4,024,000,000USD
    Ebitda—8,266,000,000USD—7,191,000,000USD9,288,000,000USD8,742,000,000USD15,607,000,000USD5,920,000,000USD
    Depreciation And Amortization—2,004,000,000USD—2,011,000,000USD1,777,000,000USD1,943,000,000USD1,772,000,000USD1,896,000,000USD
    Reconciled Depreciation—2,004,000,000USD—2,011,000,000USD1,777,000,000USD1,943,000,000USD1,772,000,000USD1,896,000,000USD
    Net Income Applicable To Common Shares———5,116,000,000USD5,152,000,000USD5,537,000,000USD10,999,000,000USD3,431,000,000USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Income YTD

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-28 · USD
    Total Revenue49,372,000,000USD
    Cost Of Revenue16,157,000,000USD
    Gross Profit33,215,000,000USD
    Research Development7,180,000,000USD
    Selling General Administrative12,466,000,000USD
    Other Operating Expenses102,000,000USD
    Total Operating Expenses19,748,000,000USD
    Operating Income13,467,000,000USD
    Total Other Income Expense Net-730,000,000USD
    Interest Income448,000,000USD
    Interest Expense553,000,000USD
    Income Before Tax12,737,000,000USD
    Income Tax Expense1,968,000,000USD
    Net Income10,769,000,000USD
    SourceDisclosureDeterministicFinal

    Income Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USDFY 20172017-12-31 · USDFY 20162016-12-31 · USDFY 20152015-12-31 · USD
    Total Revenue94,193,000,000USD88,821,000,000USD82,584,000,000USD82,059,000,000USD81,581,000,000USD76,450,000,000USD71,890,000,000USD70,074,000,000USD
    Cost Of Revenue25,635,000,000USD27,471,000,000USD28,427,000,000USD27,556,000,000USD27,091,000,000USD25,439,000,000USD21,789,000,000USD21,536,000,000USD
    Gross Profit68,558,000,000USD61,350,000,000USD54,157,000,000USD54,503,000,000USD54,490,000,000USD51,011,000,000USD50,101,000,000USD48,538,000,000USD
    Research Development14,665,000,000USD17,232,000,000USD12,340,000,000USD11,355,000,000USD10,775,000,000USD10,594,000,000USD9,143,000,000USD9,046,000,000USD
    Selling General Administrative23,676,000,000USD21,969,000,000USD22,084,000,000USD22,178,000,000USD22,540,000,000USD21,520,000,000USD20,067,000,000USD21,203,000,000USD
    Unclassified Operating Expenses4,621,000,000USD27,471,000,000USD——————
    Total Operating Expenses42,962,000,000USD66,672,000,000USD34,424,000,000USD33,533,000,000USD33,315,000,000USD32,114,000,000USD29,210,000,000USD30,249,000,000USD
    Operating Income25,596,000,000USD22,149,000,000USD19,733,000,000USD20,970,000,000USD21,175,000,000USD18,897,000,000USD20,891,000,000USD18,289,000,000USD
    Interest Income1,056,000,000USD1,332,000,000USD111,000,000USD357,000,000USD611,000,000USD385,000,000USD368,000,000USD—
    Interest Expense971,000,000USD755,000,000USD201,000,000USD318,000,000USD1,005,000,000USD934,000,000USD726,000,000USD552,000,000USD
    Net Interest Income85,000,000USD577,000,000USD-90,000,000USD39,000,000USD-394,000,000USD-549,000,000USD-358,000,000USD—
    Income Before Tax32,581,000,000USD16,687,000,000USD16,497,000,000USD17,328,000,000USD17,999,000,000USD17,673,000,000USD19,803,000,000USD19,196,000,000USD
    Income Tax Expense5,777,000,000USD2,621,000,000USD1,783,000,000USD2,209,000,000USD2,702,000,000USD16,373,000,000USD3,263,000,000USD3,787,000,000USD
    Tax Provision5,777,000,000USD2,621,000,000USD1,783,000,000USD2,209,000,000USD2,702,000,000USD16,373,000,000USD3,263,000,000USD3,787,000,000USD
    Net Income26,804,000,000USD14,066,000,000USD14,714,000,000USD15,119,000,000USD15,297,000,000USD1,300,000,000USD16,540,000,000USD15,409,000,000USD
    Net Income From Continuing Ops26,804,000,000USD14,066,000,000USD14,714,000,000USD15,119,000,000USD15,297,000,000USD1,300,000,000USD16,540,000,000USD15,409,000,000USD
    Ebit33,552,000,000USD17,442,000,000USD16,698,000,000USD17,646,000,000USD19,004,000,000USD18,607,000,000USD20,529,000,000USD19,748,000,000USD
    Ebitda41,055,000,000USD24,781,000,000USD23,929,000,000USD24,655,000,000USD25,933,000,000USD24,249,000,000USD24,283,000,000USD23,494,000,000USD
    Depreciation And Amortization7,503,000,000USD7,339,000,000USD7,231,000,000USD7,009,000,000USD6,929,000,000USD5,642,000,000USD3,754,000,000USD3,746,000,000USD
    Reconciled Depreciation7,503,000,000USD7,339,000,000USD7,231,000,000USD7,009,000,000USD6,929,000,000USD5,642,000,000USD——
    Total Other Income Expense Net6,985,000,000USD-6,045,000,000USD-3,236,000,000USD-3,642,000,000USD-3,176,000,000USD-1,224,000,000USD-1,088,000,000USD907,000,000USD
    Net Income Applicable To Common Shares26,804,000,000USD14,066,000,000USD14,714,000,000USD15,119,000,000USD15,297,000,000USD1,300,000,000USD16,540,000,000USD15,409,000,000USD
    Non Operating Income Net Other——-2,788,000,000USD-2,168,000,000USD-794,000,000USD202,000,000USD-116,000,000USD2,192,000,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-28 · USDQ1 20262026-03-31 · USDQ1 20272026-03-29 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USD
    Total Assets201,061,000,000USD200,894,000,000USD200,894,000,000USD199,210,000,000USD192,816,000,000USD193,389,000,000USD193,671,000,000USD180,104,000,000USD
    Cash And Equivalents20,422,000,000USD—21,688,000,000USD5,993,000,000USD5,298,000,000USD4,637,000,000USD19,690,000,000USD6,123,000,000USD
    Cash And Short Term Investments20,758,000,000USD22,051,000,000USD22,051,000,000USD20,102,000,000USD18,562,000,000USD18,880,000,000USD38,781,000,000USD24,522,000,000USD
    Short Term Investments336,000,000USD363,000,000USD363,000,000USD393,000,000USD331,000,000USD303,000,000USD307,000,000USD417,000,000USD
    Total Current Assets59,774,000,000USD59,173,000,000USD59,173,000,000USD55,624,000,000USD54,611,000,000USD54,498,000,000USD71,551,000,000USD55,893,000,000USD
    Other Current Assets4,826,000,000USD4,818,000,000USD4,818,000,000USD4,153,000,000USD4,292,000,000USD4,360,000,000USD4,091,000,000USD—
    Other Non Current Assets14,269,000,000USD—14,105,000,000USD—————
    Total Liabilities116,090,000,000USD—119,708,000,000USD—————
    Total Current Liabilities54,895,000,000USD57,716,000,000USD57,716,000,000USD54,126,000,000USD50,869,000,000USD54,180,000,000USD56,903,000,000USD50,321,000,000USD
    Other Current Liabilities9,464,000,000USD—7,399,000,000USD—————
    Other Non Current Liabilities10,101,000,000USD—10,208,000,000USD—————
    Total Stockholder Equity84,971,000,000USD81,186,000,000USD81,186,000,000USD81,544,000,000USD79,277,000,000USD78,473,000,000USD78,109,000,000USD71,490,000,000USD
    Total Equity Including Noncontrolling Interest84,971,000,000USD—81,186,000,000USD—————
    Long Term Debt37,344,000,000USD37,527,000,000USD37,527,000,000USD39,438,000,000USD39,408,000,000USD39,235,000,000USD38,355,000,000USD30,651,000,000USD
    Net Receivables19,046,000,000USD17,721,000,000USD17,721,000,000USD17,178,000,000USD17,611,000,000USD17,846,000,000USD16,020,000,000USD18,927,000,000USD
    Inventory15,144,000,000USD14,583,000,000USD14,583,000,000USD14,191,000,000USD14,146,000,000USD13,412,000,000USD12,659,000,000USD12,444,000,000USD
    Property Plant Equipment Net23,582,000,000USD54,695,000,000USD23,270,000,000USD23,169,000,000USD53,375,000,000USD21,949,000,000USD20,871,000,000USD20,518,000,000USD
    Goodwill48,479,000,000USD—48,558,000,000USD—————
    Intangible Assets48,229,000,000USD49,061,000,000USD49,061,000,000USD50,403,000,000USD48,737,000,000USD49,835,000,000USD36,755,000,000USD37,618,000,000USD
    Accounts Payable9,223,000,000USD10,460,000,000USD10,460,000,000USD11,991,000,000USD9,625,000,000USD9,464,000,000USD9,545,000,000USD10,311,000,000USD
    Short Term Debt11,692,000,000USD17,460,000,000USD—8,495,000,000USD6,387,000,000USD11,526,000,000USD13,897,000,000USD5,983,000,000USD
    Common Stock3,120,000,000USD3,120,000,000USD3,120,000,000USD3,120,000,000USD3,120,000,000USD3,120,000,000USD3,120,000,000USD3,120,000,000USD
    Accumulated Other Comprehensive Income-13,951,000,000USD-14,831,000,000USD-14,831,000,000USD-14,930,000,000USD-15,237,000,000USD-14,305,000,000USD-11,740,000,000USD-11,741,000,000USD
    Total Liab—119,708,000,000USD—117,666,000,000USD113,539,000,000USD114,916,000,000USD115,562,000,000USD108,614,000,000USD
    Other Current Liab—28,709,000,000USD—33,640,000,000USD32,929,000,000USD31,525,000,000USD29,244,000,000USD30,255,000,000USD
    Capital Stock—3,120,000,000USD—3,120,000,000USD3,120,000,000USD3,120,000,000USD3,120,000,000USD3,120,000,000USD
    Retained Earnings—169,161,000,000USD169,161,000,000USD168,978,000,000USD167,281,000,000USD165,371,000,000USD162,635,000,000USD155,791,000,000USD
    Good Will—48,558,000,000USD—48,772,000,000USD48,048,000,000USD48,117,000,000USD44,468,000,000USD44,200,000,000USD
    Cash—21,688,000,000USD—19,709,000,000USD18,231,000,000USD18,577,000,000USD38,474,000,000USD24,105,000,000USD
    Net Debt—-4,228,000,000USD—28,224,000,000USD27,564,000,000USD32,184,000,000USD13,778,000,000USD12,529,000,000USD
    Short Long Term Debt—17,460,000,000USD—8,495,000,000USD6,387,000,000USD11,526,000,000USD13,897,000,000USD5,983,000,000USD
    Short Long Term Debt Total—54,987,000,000USD—47,933,000,000USD45,795,000,000USD50,761,000,000USD52,252,000,000USD36,634,000,000USD
    Property Plant Equipment Gross—54,695,000,000USD—54,364,000,000USD53,375,000,000USD52,472,000,000USD49,884,000,000USD48,768,000,000USD
    Common Stock Shares Outstanding—2,445,200,000shares—2,439,000,000shares2,428,600,000shares2,419,100,000shares2,423,800,000shares2,427,100,000shares
    Non Current Assets Total—141,721,000,000USD—143,586,000,000USD138,205,000,000USD138,891,000,000USD122,120,000,000USD124,211,000,000USD
    Non Current Liabilities Total—61,992,000,000USD—63,540,000,000USD62,670,000,000USD60,736,000,000USD58,659,000,000USD58,293,000,000USD
    Non Current Liabilities Other—10,208,000,000USD—9,868,000,000USD9,926,000,000USD10,263,000,000USD10,435,000,000USD17,549,000,000USD
    Non Currrent Assets Other—-17,320,000,000USD—14,368,000,000USD-18,621,000,000USD12,189,000,000USD11,534,000,000USD11,414,000,000USD
    Net Working Capital—1,457,000,000USD—1,498,000,000USD3,742,000,000USD318,000,000USD14,648,000,000USD5,572,000,000USD
    Unclassified Non Current Assets—-10,593,000,000USD—-12,403,000,000USD-30,464,000,000USD-11,736,000,000USD-10,761,000,000USD-9,863,000,000USD
    Unclassified Current Liabilities—-16,373,000,000USD—-8,495,000,000USD-4,459,000,000USD-9,861,000,000USD-9,680,000,000USD-2,211,000,000USD
    Unclassified Non Current Liabilities—14,257,000,000USD—14,234,000,000USD13,336,000,000USD11,238,000,000USD9,869,000,000USD10,093,000,000USD
    Unclassified Equity—-79,384,000,000USD—-78,744,000,000USD-79,007,000,000USD-78,833,000,000USD-79,026,000,000USD-78,800,000,000USD
    Other Assets———19,277,000,000USD18,509,000,000USD18,537,000,000USD19,253,000,000USD20,324,000,000USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Total Assets199,210,000,000USD180,104,000,000USD167,558,000,000USD187,378,000,000USD182,018,000,000USD174,894,000,000USD157,728,000,000USD152,954,000,000USD
    Intangible Assets50,403,000,000USD37,618,000,000USD34,175,000,000USD38,489,000,000USD46,392,000,000USD53,402,000,000USD47,643,000,000USD47,611,000,000USD
    Other Current Assets4,153,000,000USD—4,514,000,000USD5,830,000,000USD3,701,000,000USD3,132,000,000USD2,486,000,000USD3,649,000,000USD
    Total Liab117,666,000,000USD108,614,000,000USD98,784,000,000USD110,574,000,000USD107,995,000,000USD111,616,000,000USD98,257,000,000USD93,202,000,000USD
    Total Stockholder Equity81,544,000,000USD71,490,000,000USD68,774,000,000USD76,804,000,000USD74,023,000,000USD63,278,000,000USD59,471,000,000USD59,752,000,000USD
    Other Current Liab33,640,000,000USD30,255,000,000USD30,206,000,000USD30,937,000,000USD29,293,000,000USD28,965,000,000USD23,952,000,000USD20,079,000,000USD
    Common Stock3,120,000,000USD3,120,000,000USD3,120,000,000USD3,120,000,000USD3,120,000,000USD3,120,000,000USD3,120,000,000USD3,120,000,000USD
    Capital Stock3,120,000,000USD3,120,000,000USD3,120,000,000USD3,120,000,000USD3,120,000,000USD3,120,000,000USD3,120,000,000USD3,120,000,000USD
    Retained Earnings168,978,000,000USD155,791,000,000USD153,843,000,000USD128,345,000,000USD123,060,000,000USD113,890,000,000USD110,659,000,000USD106,216,000,000USD
    Good Will48,772,000,000USD44,200,000,000USD36,558,000,000USD36,047,000,000USD35,246,000,000USD36,393,000,000USD33,639,000,000USD30,453,000,000USD
    Other Assets8,600,000USD20,324,000,000USD17,959,000,000USD17,049,000,000USD17,155,000,000USD3,896,000,000USD11,408,000,000USD11,305,000,000USD
    Cash19,709,000,000USD24,105,000,000USD21,859,000,000USD12,889,000,000USD14,487,000,000USD13,985,000,000USD17,305,000,000USD18,107,000,000USD
    Cash And Equivalents5,993,000,000USD6,123,000,000USD4,814,000,000USD5,368,000,000USD1,901,000,000USD2,102,000,000USD2,864,000,000USD3,397,000,000USD
    Cash And Short Term Investments20,102,000,000USD24,522,000,000USD22,927,000,000USD22,281,000,000USD31,608,000,000USD25,185,000,000USD19,287,000,000USD19,687,000,000USD
    Total Current Assets55,624,000,000USD55,893,000,000USD53,495,000,000USD55,294,000,000USD60,979,000,000USD51,237,000,000USD45,274,000,000USD46,033,000,000USD
    Total Current Liabilities54,126,000,000USD50,321,000,000USD46,282,000,000USD55,802,000,000USD45,226,000,000USD42,493,000,000USD35,964,000,000USD31,230,000,000USD
    Net Debt28,224,000,000USD12,529,000,000USD7,473,000,000USD26,753,000,000USD19,264,000,000USD21,281,000,000USD10,391,000,000USD12,373,000,000USD
    Short Term Debt8,495,000,000USD5,983,000,000USD3,451,000,000USD12,756,000,000USD3,766,000,000USD2,631,000,000USD1,202,000,000USD2,796,000,000USD
    Short Long Term Debt8,495,000,000USD5,983,000,000USD3,451,000,000USD12,771,000,000USD3,766,000,000USD2,631,000,000USD1,202,000,000USD2,796,000,000USD
    Short Long Term Debt Total47,933,000,000USD36,634,000,000USD29,332,000,000USD39,642,000,000USD33,751,000,000USD35,266,000,000USD27,696,000,000USD30,480,000,000USD
    Long Term Debt39,438,000,000USD30,651,000,000USD25,881,000,000USD26,888,000,000USD29,985,000,000USD32,635,000,000USD26,494,000,000USD27,684,000,000USD
    Short Term Investments393,000,000USD417,000,000USD1,068,000,000USD9,392,000,000USD17,121,000,000USD11,200,000,000USD1,982,000,000USD1,580,000,000USD
    Net Receivables17,178,000,000USD18,927,000,000USD14,873,000,000USD16,915,000,000USD18,984,000,000USD13,576,000,000USD14,481,000,000USD14,098,000,000USD
    Inventory14,191,000,000USD12,444,000,000USD11,181,000,000USD10,268,000,000USD10,387,000,000USD9,344,000,000USD9,020,000,000USD8,599,000,000USD
    Accounts Payable11,991,000,000USD10,311,000,000USD9,632,000,000USD9,889,000,000USD11,055,000,000USD9,505,000,000USD8,544,000,000USD7,537,000,000USD
    Property Plant Equipment Net23,169,000,000USD20,518,000,000USD19,898,000,000USD17,982,000,000USD18,962,000,000USD18,766,000,000USD17,658,000,000USD17,035,000,000USD
    Property Plant Equipment Gross54,364,000,000USD48,768,000,000USD47,776,000,000USD49,253,000,000USD47,679,000,000USD18,766,000,000USD18,615,000,000USD17,035,000,000USD
    Accumulated Other Comprehensive Income-14,930,000,000USD-11,741,000,000USD-12,527,000,000USD-12,967,000,000USD-13,058,000,000USD-15,242,000,000USD-15,891,000,000USD-15,222,000,000USD
    Common Stock Shares Outstanding2,429,400,000shares2,429,400,000shares2,560,400,000shares2,663,900,000shares2,674,000,000shares2,670,700,000shares2,684,300,000shares2,728,700,000shares
    Non Current Assets Total143,586,000,000USD124,211,000,000USD114,063,000,000USD132,084,000,000USD121,039,000,000USD123,657,000,000USD112,454,000,000USD106,921,000,000USD
    Non Current Liabilities Total63,540,000,000USD58,293,000,000USD52,502,000,000USD54,772,000,000USD62,769,000,000USD69,123,000,000USD62,293,000,000USD61,972,000,000USD
    Non Current Liabilities Other9,868,000,000USD17,549,000,000USD13,398,000,000USD21,510,000,000USD25,297,000,000USD29,274,000,000USD29,841,000,000USD8,589,000,000USD
    Non Currrent Assets Other14,368,000,000USD11,414,000,000USD14,153,000,000USD30,619,000,000USD10,216,000,000USD6,562,000,000USD5,695,000,000USD4,182,000,000USD
    Net Working Capital1,498,000,000USD5,572,000,000USD7,213,000,000USD-508,000,000USD15,753,000,000USD8,744,000,000USD9,310,000,000USD14,803,000,000USD
    Unclassified Non Current Assets6,865,400,000USD-9,863,000,000USD-8,680,000,000USD-8,102,000,000USD-6,932,000,000USD4,638,000,000USD-4,738,000,000USD-4,182,000,000USD
    Unclassified Current Liabilities-8,495,000,000USD-2,211,000,000USD-3,451,000,000USD-10,551,000,000USD-2,654,000,000USD-1,239,000,000USD-6,755,000,000USD-9,618,000,000USD
    Unclassified Non Current Liabilities14,234,000,000USD10,093,000,000USD13,223,000,000USD-26,584,000,000USD-31,784,000,000USD-35,388,000,000USD-35,083,000,000USD-16,092,000,000USD
    Unclassified Equity-78,744,000,000USD-78,800,000,000USD-3,120,000,000USD-3,120,000,000USD-3,120,000,000USD-3,120,000,000USD-3,120,000,000USD-3,120,000,000USD
    Current Deferred Revenue——2,993,000,000USD———7,819,000,000USD7,640,000,000USD
    Additional Paid In Capital——0USD0USD0USD0USD0USD0USD
    Treasury Stock——-75,662,000,000USD-41,694,000,000USD-39,099,000,000USD-38,490,000,000USD-38,417,000,000USD-34,362,000,000USD
    Deferred Long Term Liab———6,374,000,000USD7,487,000,000USD7,214,000,000USD5,958,000,000USD7,506,000,000USD
    Other Liab———26,584,000,000USD31,784,000,000USD35,388,000,000USD35,083,000,000USD34,285,000,000USD
    Net Tangible Assets———-16,752,000,000USD-13,073,000,000USD-26,517,000,000USD-21,811,000,000USD-18,312,000,000USD
    Unclassified Current Assets————-3,701,000,000USD———
    Long Term Investments——————1,149,000,000USD517,000,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow YTD

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-28 · USD
    Net Income10,769,000,000USD
    Depreciation3,963,000,000USD
    Stock Based Compensation758,000,000USD
    Deferred Income Tax-320,000,000USD
    Other Non Cash Items167,000,000USD
    Change To Account Receivables-1,947,000,000USD
    Change To Inventory-1,002,000,000USD
    Change To Liabilities-2,557,000,000USD
    Change In Working Capital-4,207,000,000USD
    Operating Cash Flow11,130,000,000USD
    Capital Expenditures-2,370,000,000USD
    Net Investments69,000,000USD
    Other Investing Activities151,000,000USD
    Investing Cash Flow-2,150,000,000USD
    Net Debt Issuance1,466,000,000USD
    Common Stock Issuance1,531,000,000USD
    Net Common Stock Issuance-2,718,000,000USD
    Common Dividends Paid-6,358,000,000USD
    Other Financing Activities-637,000,000USD
    Financing Cash Flow-8,247,000,000USD
    Effect Of Forex Changes On Cash-20,000,000USD
    Change In Cash713,000,000USD
    End Cash Flow20,422,000,000USD
    SourceDisclosureDeterministicFinal

    Cash flow Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-03-31 · USDQ1 20272026-03-29 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Net Income5,235,000,000USD—5,116,000,000USD5,152,000,000USD5,537,000,000USD10,999,000,000USD3,431,000,000USD2,694,000,000USD
    Depreciation2,004,000,000USD2,004,000,000USD2,011,000,000USD1,777,000,000USD1,943,000,000USD1,772,000,000USD1,896,000,000USD1,846,000,000USD
    Stock Based Compensation300,000,000USD300,000,000USD309,000,000USD347,000,000USD410,000,000USD288,000,000USD238,000,000USD295,000,000USD
    Other Non Cash Items42,000,000USD—16,268,000,000USD-16,270,000,000USD84,000,000USD-33,000,000USD636,000,000USD1,239,000,000USD
    Change To Account Receivables-595,000,000USD-595,000,000USD391,000,000USD111,000,000USD-1,357,000,000USD-926,000,000USD853,000,000USD-96,000,000USD
    Change To Inventory-431,000,000USD-431,000,000USD-46,000,000USD-748,000,000USD-510,000,000USD-146,000,000USD-90,000,000USD-299,000,000USD
    Change In Working Capital-5,226,000,000USD-5,226,000,000USD-12,718,000,000USD15,945,000,000USD-4,921,000,000USD-11,024,000,000USD798,000,000USD1,829,000,000USD
    Total Cash From Operating Activities2,514,000,000USD—7,309,000,000USD9,169,000,000USD3,878,000,000USD4,174,000,000USD6,983,000,000USD7,993,000,000USD
    Capital Expenditures-1,049,000,000USD-1,049,000,000USD-1,837,000,000USD-788,000,000USD-1,398,000,000USD-795,000,000USD-2,145,000,000USD-2,279,000,000USD
    Free Cash Flow1,465,000,000USD—5,472,000,000USD8,381,000,000USD2,480,000,000USD3,379,000,000USD4,838,000,000USD5,714,000,000USD
    Investments65,000,000USD—2,314,000,000USD-542,000,000USD-18,264,000,000USD-297,000,000USD-1,320,000,000USD-3,128,000,000USD
    Total Cashflows From Investing Activities-1,040,000,000USD—-4,485,000,000USD-542,000,000USD-18,264,000,000USD-297,000,000USD-1,320,000,000USD-3,128,000,000USD
    Net Borrowings7,214,000,000USD—2,105,000,000USD-5,143,000,000USD-2,376,000,000USD15,051,000,000USD1,535,000,000USD-6,431,000,000USD
    Total Cash From Financing Activities530,000,000USD—-1,369,000,000USD-8,927,000,000USD-5,665,000,000USD10,422,000,000USD-1,340,000,000USD-9,882,000,000USD
    Dividends Paid-3,131,000,000USD—-3,131,000,000USD-3,132,000,000USD-3,129,000,000USD-2,989,000,000USD-2,984,000,000USD-2,985,000,000USD
    Sale Purchase Of Stock-4,028,000,000USD—-1,924,000,000USD-1,902,000,000USD-1,570,000,000USD-2,127,000,000USD-282,000,000USD-539,000,000USD
    Change In Cash1,979,000,000USD1,979,000,000USD1,478,000,000USD-346,000,000USD-19,897,000,000USD14,369,000,000USD4,125,000,000USD-4,898,000,000USD
    Begin Period Cash Flow19,709,000,000USD—18,231,000,000USD18,577,000,000USD38,474,000,000USD24,105,000,000USD19,980,000,000USD24,878,000,000USD
    End Period Cash Flow21,688,000,000USD—19,709,000,000USD18,231,000,000USD18,577,000,000USD38,474,000,000USD24,105,000,000USD19,980,000,000USD
    Other Cashflows From Investing Activities-85,000,000USD—458,000,000USD-2,311,000,000USD-634,000,000USD266,000,000USD265,000,000USD-1,140,000,000USD
    Other Cashflows From Financing Activities-697,000,000USD—-6,000,000USD-24,000,000USD-267,000,000USD487,000,000USD391,000,000USD1,043,000,000USD
    Unclassified Operating Cash Flow159,000,000USD—-3,677,000,000USD2,218,000,000USD825,000,000USD2,172,000,000USD—90,000,000USD
    Unclassified Investing Cash Flow29,000,000USD-139,000,000USD-5,420,000,000USD3,099,000,000USD2,032,000,000USD529,000,000USD1,880,000,000USD3,419,000,000USD
    Unclassified Financing Cash Flow1,172,000,000USD-4,070,000,000USD1,587,000,000USD1,274,000,000USD1,677,000,000USD——-970,000,000USD
    Deferred Income Tax—159,000,000USD——————
    Change To Liabilities—-4,549,000,000USD——————
    Operating Cash Flow—2,514,000,000USD——————
    Net Investments—65,000,000USD——————
    Other Investing Activities—83,000,000USD——————
    Investing Cash Flow—-1,040,000,000USD——————
    Net Debt Issuance—9,216,000,000USD——————
    Net Common Stock Issuance—-4,028,000,000USD——————
    Other Financing Activities—-588,000,000USD——————
    Financing Cash Flow—530,000,000USD——————
    Effect Of Forex Changes On Cash—-25,000,000USD——————
    End Cash Flow—21,688,000,000USD——————
    Issuance Of Capital Stock——————0USD0USD
    SourceLegacy providerLegacyDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Net Income26,804,000,000USD14,066,000,000USD35,153,000,000USD17,941,000,000USD20,878,000,000USD14,714,000,000USD15,119,000,000USD15,297,000,000USD
    Depreciation7,503,000,000USD7,339,000,000USD7,486,000,000USD6,970,000,000USD7,390,000,000USD7,231,000,000USD7,009,000,000USD6,929,000,000USD
    Stock Based Compensation1,354,000,000USD1,176,000,000USD1,162,000,000USD1,138,000,000USD1,135,000,000USD1,005,000,000USD977,000,000USD978,000,000USD
    Other Non Cash Items49,000,000USD2,031,000,000USD2,504,000,000USD819,000,000USD324,000,000USD-963,000,000USD-1,078,000,000USD10,000,000USD
    Change To Account Receivables-1,781,000,000USD-406,000,000USD-624,000,000USD-1,290,000,000USD-2,402,000,000USD774,000,000USD-289,000,000USD-1,185,000,000USD
    Change To Inventory-1,450,000,000USD-1,128,000,000USD-1,323,000,000USD-2,527,000,000USD-1,248,000,000USD-265,000,000USD-277,000,000USD-644,000,000USD
    Change In Working Capital-12,718,000,000USD1,837,000,000USD2,507,000,000USD-4,011,000,000USD-4,238,000,000USD2,690,000,000USD3,865,000,000USD3,000,000USD
    Total Cash From Operating Activities24,530,000,000USD24,266,000,000USD22,791,000,000USD21,194,000,000USD23,410,000,000USD23,536,000,000USD23,416,000,000USD22,201,000,000USD
    Capital Expenditures-4,832,000,000USD-4,424,000,000USD-4,543,000,000USD-4,009,000,000USD-3,652,000,000USD-3,347,000,000USD-3,498,000,000USD-3,670,000,000USD
    Free Cash Flow19,698,000,000USD19,842,000,000USD18,248,000,000USD17,185,000,000USD19,758,000,000USD20,189,000,000USD19,918,000,000USD18,531,000,000USD
    Investments741,000,000USD-18,599,000,000USD878,000,000USD9,225,000,000USD-5,388,000,000USD-8,952,000,000USD-533,000,000USD-1,337,000,000USD
    Total Cashflows From Investing Activities-23,588,000,000USD-18,599,000,000USD878,000,000USD-12,371,000,000USD-8,683,000,000USD-20,825,000,000USD-6,194,000,000USD-3,167,000,000USD
    Net Borrowings9,637,000,000USD10,051,000,000USD-2,734,000,000USD7,452,000,000USD-990,000,000USD7,095,000,000USD-2,881,000,000USD-3,949,000,000USD
    Total Cash From Financing Activities-5,539,000,000USD-3,132,000,000USD-15,825,000,000USD-8,871,000,000USD-14,047,000,000USD-6,120,000,000USD-18,015,000,000USD-18,510,000,000USD
    Dividends Paid-12,381,000,000USD-11,823,000,000USD-11,770,000,000USD-11,682,000,000USD-11,032,000,000USD-10,481,000,000USD-9,917,000,000USD-9,494,000,000USD
    Sale Purchase Of Stock-5,953,000,000USD-2,432,000,000USD-5,054,000,000USD-6,035,000,000USD-3,456,000,000USD-3,221,000,000USD-6,746,000,000USD-5,868,000,000USD
    Issuance Of Capital Stock0USD0USD4,241,000,000USD0USD0USD———
    Change In Cash-4,396,000,000USD2,246,000,000USD7,732,000,000USD-360,000,000USD502,000,000USD-3,320,000,000USD-802,000,000USD283,000,000USD
    Begin Period Cash Flow24,105,000,000USD21,859,000,000USD14,127,000,000USD14,487,000,000USD13,985,000,000USD17,305,000,000USD18,107,000,000USD17,824,000,000USD
    End Period Cash Flow19,709,000,000USD24,105,000,000USD21,859,000,000USD14,127,000,000USD14,487,000,000USD13,985,000,000USD17,305,000,000USD18,107,000,000USD
    Other Cashflows From Investing Activities-1,956,000,000USD235,000,000USD-3,063,000,000USD-17,587,000,000USD357,000,000USD-8,526,000,000USD-2,163,000,000USD2,739,000,000USD
    Other Cashflows From Financing Activities3,158,000,000USD1,072,000,000USD-508,000,000USD17,530,000,000USD395,000,000USD-627,000,000USD575,000,000USD801,000,000USD
    Unclassified Operating Cash Flow1,538,000,000USD-2,183,000,000USD-26,021,000,000USD-1,663,000,000USD-2,079,000,000USD-1,141,000,000USD-2,476,000,000USD-1,016,000,000USD
    Unclassified Investing Cash Flow-17,541,000,000USD4,189,000,000USD7,606,000,000USD————-899,000,000USD
    Unclassified Financing Cash Flow——4,241,000,000USD-16,136,000,000USD1,036,000,000USD1,114,000,000USD954,000,000USD—
    Change To Liabilities———-881,000,000USD1,376,000,000USD5,885,000,000USD5,485,000,000USD2,107,000,000USD
    Cash And Cash Equivalents Changes———-48,000,000USD680,000,000USD-3,409,000,000USD-793,000,000USD283,000,000USD
    Exchange Rate Changes———————-241,000,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Operating metrics

    No operating metrics are currently published for this company.

    Revenue breakdown

    PeriodDimensionBusiness / regionRevenueCurrencySource
    Q1 2027Quarterly · 2026-03-29SegmentInnovative Medicine15,426,000,000USDDisclosure
    Q1 2027Quarterly · 2026-03-29SegmentMed Tech8,636,000,000USDDisclosure
    Q4 2025Quarterly · 2025-12-31SegmentInnovative Medicine15,763,000,000USDLegacy provider
    Q4 2025Quarterly · 2025-12-31SegmentMed Tech8,801,000,000USDLegacy provider
    FY 2025Yearly · 2025-12-31SegmentInnovative Medicine60,401,000,000USDDisclosure
    FY 2025Yearly · 2025-12-31SegmentMed Tech33,792,000,000USDDisclosure
    Q3 2025Quarterly · 2025-09-30SegmentInnovative Medicine15,563,000,000USDDisclosure
    Q3 2025Quarterly · 2025-09-30SegmentMed Tech8,430,000,000USDDisclosure
    Q2 2025Quarterly · 2025-06-30SegmentInnovative Medicine15,202,000,000USDDisclosure
    Q2 2025Quarterly · 2025-06-30SegmentMed Tech8,541,000,000USDDisclosure
    Q4 2024Quarterly · 2024-12-31SegmentInnovative Medicine14,332,000,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31SegmentMed Tech8,188,000,000USDLegacy provider
    FY 2024Yearly · 2024-12-31SegmentInnovative Medicine56,964,000,000USDDisclosure
    FY 2024Yearly · 2024-12-31SegmentMed Tech31,857,000,000USDDisclosure
    Q3 2024Quarterly · 2024-09-30SegmentInnovative Medicine14,580,000,000USDDisclosure
    Q3 2024Quarterly · 2024-09-30SegmentMed Tech7,891,000,000USDDisclosure
    Q2 2024Quarterly · 2024-06-30SegmentInnovative Medicine14,490,000,000USDDisclosure
    Q2 2024Quarterly · 2024-06-30SegmentMed Tech7,957,000,000USDDisclosure
    Q1 2024Quarterly · 2024-03-31SegmentInnovative Medicine13,562,000,000USDDisclosure
    Q1 2024Quarterly · 2024-03-31SegmentMed Tech7,821,000,000USDDisclosure
    FY 2023Yearly · 2023-12-31SegmentInnovative Medicine54,759,000,000USDDisclosure
    FY 2023Yearly · 2023-12-31SegmentMed Tech30,400,000,000USDDisclosure
    FY 2022Yearly · 2022-12-31SegmentInnovative Medicine52,563,000,000USDDisclosure
    FY 2022Yearly · 2022-12-31SegmentMed Tech27,427,000,000USDDisclosure
    FY 2021Yearly · 2021-12-31SegmentInnovative Medicine51,680,000,000USD0000200406-24-000013
    FY 2021Yearly · 2021-12-31SegmentMed Tech27,060,000,000USD0000200406-24-000013
    FY 2020Yearly · 2020-12-31SegmentConsumer14,450,000,000USD0000200406-23-000016
    FY 2020Yearly · 2020-12-31SegmentMed Tech22,959,000,000USD0000200406-23-000016
    FY 2020Yearly · 2020-12-31SegmentPharmaceutical45,175,000,000USD0000200406-23-000016
    FY 2019Yearly · 2019-12-31SegmentConsumer13,898,000,000USD0000200406-22-000022
    FY 2019Yearly · 2019-12-31SegmentMedical Devices25,963,000,000USD0000200406-22-000022
    FY 2019Yearly · 2019-12-31SegmentPharmaceutical42,198,000,000USD0000200406-22-000022
    FY 2018Yearly · 2018-12-31SegmentConsumer13,853,000,000USD0000200406-21-000008
    FY 2018Yearly · 2018-12-31SegmentMedical Devices26,994,000,000USD0000200406-21-000008
    FY 2018Yearly · 2018-12-31SegmentPharmaceutical40,734,000,000USD0000200406-21-000008
    Q3 2014Quarterly · 2014-09-30GeographyInternational9,625,000,000USD0000200406-14-000097
    Q3 2014Quarterly · 2014-09-30GeographyUnited States8,842,000,000USD0000200406-14-000097
    Q2 2014Quarterly · 2014-06-30GeographyInternational10,363,000,000USD0000200406-14-000089
    Q2 2014Quarterly · 2014-06-30GeographyUnited States9,132,000,000USD0000200406-14-000089
    Q1 2014Quarterly · 2014-03-31GeographyInternational9,911,000,000USD0000200406-14-000047
    Q1 2014Quarterly · 2014-03-31GeographyUnited States8,204,000,000USD0000200406-14-000047
    Q3 2013Quarterly · 2013-09-30GeographyInternational9,650,000,000USD0000200406-14-000097
    Q3 2013Quarterly · 2013-09-30GeographyUnited States7,925,000,000USD0000200406-14-000097
    Q2 2013Quarterly · 2013-06-30GeographyInternational9,931,000,000USD0000200406-14-000089
    Q2 2013Quarterly · 2013-06-30GeographyUnited States7,946,000,000USD0000200406-14-000089
    Q1 2013Quarterly · 2013-03-31GeographyInternational9,480,000,000USD0000200406-14-000047
    Q1 2013Quarterly · 2013-03-31GeographyUnited States8,025,000,000USD0000200406-14-000047
    Q3 2012Quarterly · 2012-09-30GeographyInternational9,261,000,000USD0000200406-13-000112
    Q3 2012Quarterly · 2012-09-30GeographyUnited States7,791,000,000USD0000200406-13-000112
    Q2 2012Quarterly · 2012-06-30GeographyInternational9,115,000,000USD0000200406-13-000091
    Q2 2012Quarterly · 2012-06-30GeographyUnited States7,360,000,000USD0000200406-13-000091

    Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.